Anemia como factor pronóstico independiente en pacientes con carcinoma renal

Chow, 1999, Rising incidence of renal cell cancer in the United States, JAMA, 281, 1628, 10.1001/jama.281.17.1628 La Vecchia, 1992, Descriptive epidemiology of kidney cancer in Europe, J Nephrol, 5, 37 Thoenes, 1986, Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas): The basic cytological and histopathologycal elements and their use for diagnostics, Pathol Res Pract, 181, 125, 10.1016/S0344-0338(86)80001-2 Mostofi, 1998 Kovacs, 1993, Molecular differential pathology of renal cell tumours, Histopathology, 43, 7 Hellstens, 1981, Unrecognized renal cell carcinoma. Clinical and diagnostic aspects, Scand J Urol Nephrol, 15, 269, 10.3109/00365598109179615 McNicholls, 1981, Renal cell carcinoma: Long-term survival and late recurrence, J Urol, 126, 17, 10.1016/S0022-5347(17)54359-1 Giberti, 1997, Radical nephrectomy for renal cell carcinoma: Long-term results and prognostic factors on a series of 328 cases, Eur Urol, 31, 40, 10.1159/000474416 Aso, 1992, A survey on incidental renal cell carcinoma in Japan, J Urol, 147, 340, 10.1016/S0022-5347(17)37231-2 Campbell SC, Novick AC, Bukowski RM. Renal tumors. En: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editores. Campbell′s Urology. 9 ed. Filadelfia, USA: WB Saunders & Co; 2007. p. 1567–811. Andrews PC, Novick DE. Síndromes urológicos paraneoplásicos. AUA Update series 1996; Lección 32:69. Citterio, 1997, Prognostic factors for survival in metastatic renal cell carcinoma: Retrospective analysis from 109 consecutive patients, Eur Urol, 31, 286, 10.1159/000474469 2002, 193 Fuhrman, 1982, Prognostic significance of morphologic parameters in renal cell carcinoma, Am J Surg Pathol, 6, 655, 10.1097/00000478-198210000-00007 Javidan, 1999, Prognostic significance of the 1997 TNM classification of renal cell carcinoma, J Urol, 162, 1277, 10.1016/S0022-5347(05)68264-X Gettman, 2001, Pathologic staging of renal cell carcinoma: Significance of tumor classification with the 1997 TNM staging system, Cancer, 91, 354, 10.1002/1097-0142(20010115)91:2<354::AID-CNCR1009>3.0.CO;2-9 Salama, 2005, pT1 substaging in renal cell carcinoma: Validation of the 2002 TNM staging modification of malignant tenal epithelial tumors, J Urol, 173, 1492, 10.1097/01.ju.0000154693.68717.12 Leibovich, 2005, Cancer specific survival for patients with pT3 renal cell carcinoma –can the 2002 primary tumor classification be improved?, J Urol, 173, 716, 10.1097/01.ju.0000151830.27750.d2 Thompson, 2005, Should direct ipsilateral adrenal invasion from renal cell carcinoma be classified as pT3a?, J Urol, 173, 918, 10.1097/01.ju.0000153419.98715.24 Lerner, 1996, Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery, J Urol, 155, 1868, 10.1016/S0022-5347(01)66032-4 Hafez, 1999, Nephron sparing surgery for localized renal cell carcinoma: Impact of tumor size on patient survival, tumor recurrence and TNM staging, J Urol, 162, 1930, 10.1016/S0022-5347(05)68071-8 Méjean, 2003, Prognostic factors of renal cell carcinoma, J Urol, 169, 821, 10.1097/01.ju.0000051378.14270.2a Ficarra, 2002, Prognostic factors in patients with renal cell carcinoma: Retrospective analysis of 675 cases, Eur Urol, 41, 190, 10.1016/S0302-2838(01)00027-6 Hemmerlein, 2001, Vascular endothelial growth factor expression, angiogenesis, and necrosis in renal cell carcinomas, Virchows Arch, 439, 645, 10.1007/s004280100464 Cheville, 2003, Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma, Am J Surg Pathol, 27, 612, 10.1097/00000478-200305000-00005 Van Brussel, 1999, Prognostic factors in renal cell and bladder cancer, BJU Int, 83, 902, 10.1046/j.1464-410x.1999.00120.x Rivas del Fresno, 1995, Nuestra experiencia con el adenocarcinoma renal (II): curso clínico, diagnóstico y factores pronósticos antes del tratamiento quirúrgico, Arch Esp Urol, 48, 61 Gelb, 1997, Renal cell carcinoma: Current prognostic factors. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC), Cancer, 80, 981, 10.1002/(SICI)1097-0142(19970901)80:5<981::AID-CNCR23>3.3.CO;2-Y Yasunaga, 1998, Prognostic factors of renal cell carcinoma: A multivariate analysis, J Surg Oncol, 68, 11, 10.1002/(SICI)1096-9098(199805)68:1<11::AID-JSO4>3.0.CO;2-O Gold, 1996, Paraneoplastic manifestations of renal cell carcinoma, Semin Urol Oncol, 14, 216 Henson, 1995, College of American Pathologists Conference XXVI on clinical relevance of prognostic markers in solid tumors. Summary. Members of the Cancer Committee, Arch Pathol Lab Med, 119, 1109 Fein, 1995, Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx, J Clin Oncol, 13, 2077, 10.1200/JCO.1995.13.8.2077 Caro, 2002, Anemia as an independent prognostic factor for survival in patients with cancer: A systemic, quantitative review, Cancer, 94, 2793, 10.1002/cncr.10523 García Prim, 2008, Efecto del valor de la hemoglobina en la supervivencia del cáncer de pulmón, Med Clin (Barc), 131, 601, 10.1157/13127916 Alberola, 2008, Anemia asociada al cáncer de pulmón: ¿factor pronóstico, predictivo, ambos o ninguno?, Med Clin (Barc), 131, 612, 10.1157/13127919 Motzer, 1999, Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma, J Clin Oncol, 17, 2530, 10.1200/JCO.1999.17.8.2530 Zisman, 2002, Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma, J Clin Oncol, 20, 4559, 10.1200/JCO.2002.05.111 Cindolo, 2008, Validation by calibration of the UCLA integrated staging system prognostic model for nonmetastatic renal cell carcinoma after nephrectomy, Cancer, 113, 65, 10.1002/cncr.23517